Pantazaki Anastasia

Pantazaki Anastasia

Professor

Biochemistry Laboratory
Aristotle University of Thessaloniki
Faculty of Sciences
School of Chemistry
54124, Thessaloniki

EDUCATION/TRAINING

1976-1978 DEUG B (Diplôme d’études d’Univ. Generals), Université de Grenoble, France

1978-1982 B. A. in Chemistry, AUTh, Greece

1982-1984 Chemist position in industry

1984-1989 Ph. D. in Biochemistry, AUTh, Greece

1989-1991: Teacher of Chemistry-Biology in High school

ACADEMIC APPOINTMENTS-Aristotle University of Thessaloniki

2018 Professor; 2013-2018: Associate Professor; 2004-2013: Assistant Professor; 2000-2004: Lecturer; 1991-2000: Scientific Collaborator at Dept. of Chemistry, Lab. of Biochemistry, Univ. of Thessaloniki.

POSTDOCTORAL STUDIES IN OTHER UNIVERSITIES

Centre National de Recherche Scientifique, Laboratoire de la Recherche sur les Polymères, Univ. Paris XII, France ; Laboratoire de Spectrochimie Infrarouge et Raman, Univ. Paris VI, France ; Lab. de protéines and nanotechnologies in séparation sciences, Univ. Paris-Saclay, Faculté de Pharmacie, Chatenay-Malabry, France

LABORATORY WORK

Advisor of PhDs (5), Supervisor for Diploma Thesis of chemists (31), Advisor (20)/Co-advisor of Msc of Biochemistry (24), Advisor (4)/Co-advisor (8).

PUBLICATIONS

English papers (110 in Scopus, Pubmed); Citations>2496; Impact Factor>230 and h-index=30; 2. Chapters in Books (13); 3. Greek papers (25).

RESEARCH AND TRAINING PROJECTS FUNDED (10),

PATENTS (3)

Teaching

  • Biochemistry ΙΙ (Υ17) (Dept. of Chemistry, Dept. of Pharmacy)
  • Biotechnology (Κ314)
  • Enzymology (Κ315) (Dept. of Chemistry, Dept. of Biology)
  • Molecular mechanisms of signal transduction (Postgraduate AUTh)
  • Metabolic processes (Postgraduate AUTh)
  • Molecular Biotechnology (Postgraduate AUTh)
  • Bio-Medical and Molecular Sciences in Disease Diagnosis and Treatment (Postgraduate of Medicine, University of Thrace)
  • Epidemiology and pathogenesis of dementia (Postgraduate of Medicine, AUTh)

Research

Biochemistry

 
  • Factors Affecting Alzheimer’s Disease, Biomarkers -Therapeutic Approaches-Oxidative Stress-Microbiome and Microbial Metabolites.
  • Biological activity of new compounds, complexes, nanoparticles, natural products, toxic agents.
  • Action of enzymes and natural compounds of biotechnological interest, immobilization-encapsulation techniques on nanocarriers (liposomes, nanoparticles-nanomaterials, polymeric carriers or others.
  • Investigation of new enzymatic inhibitors of therapeutic interest
  • DNA damage with Comet assay by toxic agents-pollutants- PolyADP-ribose polymerase
  • Antimicrobial and antifungal activity of new agents
  • Iron transport systems – siderophores

Biotechnology

  • Bacterial biodegradable biopolymer: Biosynthesis and biodegradation of biopolymers (polyhydroxyalkanoic acids) in the presence of various carbon sources and mainly using industrial by-products such as whey in order to synthesize products with high added value. Purification and study of enzymes involved in these two processes (polyhydroxyalkanoic acid synthase and depolymerase, keto thiolase etc.)
  • Microbial fermentation for exploiting wastes, microbial cells and enzyme technology to produce high value-added products (biodegradable biopolymers, bio-surfactants, siderophores etc.)
  • Enzymes immobilization for biotechnological applications